The latest price target for Artivion (NYSE:AORT) was reported by Canaccord Genuity on June 16, 2026. The analyst firm set a price target for $36.00 expecting AORT to rise to within 12 months (a possible 46.94% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Artivion (NYSE:AORT) was provided by Canaccord Genuity, and Artivion maintained their buy rating.

The last upgrade for Artivion Inc happened on April 10, 2026 when Ladenburg Thalmann raised their price target to $42. Ladenburg Thalmann previously had a neutral for Artivion Inc.

The last downgrade for Artivion Inc happened on August 13, 2025 when Ladenburg Thalmann changed their price target from $32 to $38.8 for Artivion Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artivion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artivion was filed on June 16, 2026 so you should expect the next rating to be made available sometime around June 16, 2027.

While ratings are subjective and will change, the latest Artivion (AORT) rating was a maintained with a price target of $36.00 to $36.00. The current price Artivion (AORT) is trading at is $24.50, which is out of the analyst’s predicted range.